Citadel Advisors
SHC icon

Citadel Advisors’s Sotera Health SHC Stock Holding History

Citadel Advisors’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.6M Buy
2,005,163
+1,313,776
+190% +$20.7M ﹤0.01% 1910
2026
Q1 		$9.91M Buy
691,387
+86,543
+14% +$1.44M ﹤0.01% 3270
2025
Q4 		$10.7M Buy
604,844
+49,733
+9% +$822K ﹤0.01% 3176
2025
Q3 		$8.73M Buy
555,111
+467,074
+531% +$6.56M ﹤0.01% 3474
2025
Q2 		$979K Buy
88,037
+16,353
+23% +$192K ﹤0.01% 7140
2025
Q1 		$836K Buy
+71,684
New +$923K ﹤0.01% 7351
2024
Q4 		– Sell
-2,201,031
Closed -$31.9M – 15294
2024
Q3 		$36.8M Buy
2,201,031
+1,533,159
+230% +$22.4M 0.01% 1503
2024
Q2 		$7.93M Sell
667,872
-42,704
-6% -$487K ﹤0.01% 3079
2024
Q1 		$8.53M Buy
710,576
+594,267
+511% +$8.84M ﹤0.01% 3139
2023
Q4 		$1.96M Sell
116,309
-588,292
-83% -$8.33M ﹤0.01% 5390
2023
Q3 		$10.6M Sell
704,601
-3,162,928
-82% -$53.4M ﹤0.01% 2627
2023
Q2 		$72.9M Sell
3,867,529
-1,432,948
-27% -$22.8M 0.02% 800
2023
Q1 		$94.9M Buy
5,300,477
+605,312
+13% +$10.1M 0.02% 640
2022
Q4 		$39.1M Buy
4,695,165
+363,584
+8% +$2.71M 0.01% 1317
2022
Q3 		$29.5M Buy
4,331,581
+3,245,382
+299% +$54M 0.01% 1489
2022
Q2 		$21.3M Sell
1,086,199
-35,486
-3% -$743K 0.01% 1784
2022
Q1 		$24.3M Buy
1,121,685
+58,949
+6% +$1.25M 0.01% 1766
2021
Q4 		$25M Buy
+1,062,736
New +$25.4M 0.01% 1773
2021
Q2 		– Sell
-1,231,176
Closed -$30.7M – 14344
2021
Q1 		$30.7M Sell
1,231,176
-808,166
-40% -$21.4M 0.01% 1490
2020
Q4 		$56M Buy
+2,039,342
New +$54.7M 0.01% 869

Other funds holding SHC

SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM

Citadel Advisors's SHC Position: Q2 2026 in Review

Citadel Advisors increased its Sotera Health (SHC) stake by 190% in Q2 2026, buying an estimated $20.7M and bringing the position to 2,005,163 shares worth $35.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1910.

Citadel Advisors first reported a position in SHC in Q4 2020 and has held it in 20 quarters since. The position peaked at $94.9M in Q1 2023. 320 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Citadel Advisors held 2,005,163 shares of Sotera Health worth $35.6M as of Q2 2026.
  • Citadel Advisors bought 1,313,776 Sotera Health shares in Q2 2026, an estimated $20.7M.
  • Sotera Health made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #1910 holding.
  • Citadel Advisors first reported a position in Sotera Health in Q4 2020 and has held it in 20 quarters since.
  • Citadel Advisors's Sotera Health position peaked at $94.9M in Q1 2023.
  • 320 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.